Cao K - Search Results

1

LINC00669 promotes lung adenocarcinoma growth by stimulating the Wnt/β-catenin signaling pathway.

Zhu J, Cao K, Zhang P, Ma J. Zhu J, et al. Among authors: cao k. Cancer Med. 2023 Apr;12(7):9005-9023. doi: 10.1002/cam4.5604. Epub 2023 Jan 9. Cancer Med. 2023. PMID: 36621836 Free PMC article.

2

Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer.

Zhu J, Liu Y, Zhao M, Cao K, Ma J, Peng S. Zhu J, et al. Among authors: cao k. Aging (Albany NY). 2021 Jan 20;13(3):4482-4502. doi: 10.18632/aging.202408. Epub 2021 Jan 20. Aging (Albany NY). 2021. PMID: 33495411 Free PMC article.

3

UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma.

Wang X, Liu Y, Leng X, Cao K, Sun W, Zhu J, Ma J. Wang X, et al. Among authors: cao k. Pathol Oncol Res. 2021 Apr 9;27:632531. doi: 10.3389/pore.2021.632531. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257599 Free PMC article.

4

UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.

Zhu J, Ao H, Liu M, Cao K, Ma J. Zhu J, et al. Among authors: cao k. J Transl Med. 2021 Aug 30;19(1):374. doi: 10.1186/s12967-021-03056-1. J Transl Med. 2021. PMID: 34461934 Free PMC article.

5

Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma.

Cao K, Liu M, Ma K, Jiang X, Ma J, Zhu J. Cao K, et al. Cancer Immunol Immunother. 2022 Jun;71(6):1295-1311. doi: 10.1007/s00262-021-03069-1. Epub 2021 Oct 15. Cancer Immunol Immunother. 2022. PMID: 34652523 Free PMC article.

6

Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.

Cao K, Ma T, Ling X, Liu M, Jiang X, Ma K, Zhu J, Ma J. Cao K, et al. Ann Transl Med. 2021 Oct;9(20):1591. doi: 10.21037/atm-21-5217. Ann Transl Med. 2021. PMID: 34790797 Free PMC article.

7

LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway.

Ma J, Cao K, Ling X, Zhang P, Zhu J. Ma J, et al. Among authors: cao k. Cancers (Basel). 2022 Jun 8;14(12):2845. doi: 10.3390/cancers14122845. Cancers (Basel). 2022. PMID: 35740511 Free PMC article.

8

Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.

Cao K, Ling X, Jiang X, Ma J, Zhu J. Cao K, et al. Respir Res. 2022 Nov 10;23(1):306. doi: 10.1186/s12931-022-02226-z. Respir Res. 2022. PMID: 36357897 Free PMC article.

9

Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations.

Bai Y, Cao K, Zhang P, Ma J, Zhu J. Bai Y, et al. Among authors: cao k. Int J Mol Sci. 2022 Dec 26;24(1):375. doi: 10.3390/ijms24010375. Int J Mol Sci. 2022. PMID: 36613817 Free PMC article.

10

Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1.

Zhu J, Cao K, Zhao M, Ma K, Jiang X, Bai Y, Ling X, Ma J. Zhu J, et al. Among authors: cao k. Mol Med. 2023 Jan 16;29(1):6. doi: 10.1186/s10020-023-00602-z. Mol Med. 2023. PMID: 36647009 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,031 results

Search Page

Filters